BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Curemark LLC

Headquarters: Rye, NY, United States
Year Founded: 2004
Status: Private

BioCentury | Apr 14, 2023
Management Tracks

Editas names Reeve chair, adds Levy to board

Plus: Exelixis proposes new directors amid ongoing tussle with activist investor and updates from Jasper, CIRM, Visus, Curemark and more
BioCentury | Sep 23, 2022
Management Tracks

Third Rock’s Finer becomes Septerna’s full-time CEO 

Plus Thieroff-Ekerdt to head clinical development at Cambrian and an update from Curemark
BioCentury | May 23, 2017
Regulation

Misalignment in autism

FDA workshop reveals diversity of priorities among autism patients, caregivers
BioCentury | Jul 20, 2015
Financial News

Curemark completes venture financing

BioCentury | May 25, 2015
Clinical News

CM-AT: Phase III started

BioCentury | Nov 11, 2013
Clinical News

CM-AT regulatory update

BioCentury | Nov 5, 2013
Company News

Curemark begins rolling NDA for autism product

BioCentury | Oct 14, 2013
Financial News

Curemark completes venture financing

BioCentury | Oct 9, 2013
Financial News

Curemark closes $18.5 million equity financing

BioCentury | Jul 23, 2012
Company News

Curemark management update

Items per page:
1 - 10 of 17